A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Clinical trial NCT03152318 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03152318
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma of Brain Astrocytoma Malignant Astrocytoma Oligodendroglioma Anaplastic Oligodendroglioma of Brain (Diagnosis)Mixed Oligo-Astrocytoma Ependymoma Ganglioglioma Pylocytic/Pylomyxoid Astrocytoma Brain Tumor Glioma Brain Cancer

Start date: 2017-07-18
Primary completion: 2027-01-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.